• Health & Medicine

Promising immunotherapy drug now available for some lung cancer patients in England

A new recommendation by NICE gives certain lung cancer patients access to the immunotherapy drug nivolumab, through the Cancer Drugs Fund. A new recommendation by NICE gives certain lung cancer patients access to the immunotherapy drug nivolumab, through the Cancer Drugs Fund.

21 September 2017

• Health & Medicine

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care. A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

31 August 2017

• Health & Medicine

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours. Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

10 August 2017

• Science & Technology
• Health & Medicine

Lung cancer discovery points to a better way to personalise immunotherapy

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t. New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.

27 June 2017

• Health & Medicine

Tumour characteristics could predict immunotherapy success in lung cancer

The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found. The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.

23 June 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.

19 June 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 4

We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves. We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.

23 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 3

We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves. We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.

22 May 2017

• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 2

We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves. We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.

21 May 2017